Sevibe Cells
Sevibe Cells is a Spanish private cord blood and tissue bank serving expectant parents nationwide, with two processing laboratories in Madrid and Girona, AABB accreditation, and distribution via 1,500+ hospital partnerships and health insurer deals.
- Company typePrivate
- Founded2004
- HeadquartersBarcelona, Spain
- Headcount—
- GTM typeB2C
- OfferingServices
What Sevibe Cells does
Sevibe Cells is a Spanish private cord blood and tissue bank headquartered in Barcelona, founded in 2004 and operating as a subsidiary of the FamiCord Group since 2012. The company collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and cord tissue at two laboratories in Madrid (AABB-accredited) and Girona (UNE-EN ISO 9001 certified), serving expectant parents in Spain through a direct-to-consumer model supplemented by partnerships with more than 1,500 hospitals and clinics and several leading health insurers.
The company's core offering is a one-time biological capture service priced as an upfront collection-and-processing fee combined with recurring annual storage fees, generating a long-tail subscription-style revenue stream with high customer retention. Beyond cryopreservation, Sevibe Cells has expanded its value proposition upstream with streaming childbirth preparation courses and a digital pregnancy calendar, seeking to engage expectant families earlier in the decision journey. The Madrid facility holds AABB accreditation — a globally recognized cord blood banking standard — while both labs operate under ISO 9001 quality systems and GDPR-compliant data handling.
Commercial go-to-market relies on regional offices across multiple Spanish cities, direct digital marketing, on-site hospital relationships, and insurer partnerships that embed the service into benefits packages. As a member of the FamiCord Group — the largest cord blood bank in Europe — Sevibe Cells benefits from group-level procurement, R&D, and processing scale, while contributing to the parent's broader pan-European biobank. The category is mature and regulated, with competitive differentiation anchored on accreditation, brand trust, hospital footprint, and lifetime biological continuity rather than technological novelty.
Sevibe Cells firmographics
Firmographics- Name
- Sevibe Cells
- Legal name
- SEVIBE CELLS S.L.
- Website
- https://sevibe.es
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Short description
- Sevibe Cells is a Spanish private cord blood and tissue bank serving expectant parents nationwide, with two processing laboratories in Madrid and Girona, AABB accreditation, and distribution via 1,500+ hospital partnerships and health insurer deals.
- Ownership category
- akta.pro rank
Sevibe Cells industry classification
Industry- Product category
- Cord Blood Banking / Stem Cell Banking Services
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
Keywords
Where Sevibe Cells is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices8 records
Markets served
Sevibe Cells business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Umbilical Cord Blood Stem Cell Preservation: Collection, processing, testing, and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood for autologous (family) use. Service includes sample collection kit, laboratory processing, quality testing, and annual storage fees.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Sevibe Cells product offering
Product offeringCore offering
Sevibe Cells is an autologous umbilical cord blood and tissue stem cell bank that collects, processes, tests, and cryopreserves hematopoietic and mesenchymal stem cells at childbirth for potential future family medical use. The company operates two proprietary AABB-accredited processing laboratories in Spain (Madrid and Girona) and delivers the sample collection kits to partner hospitals where cord blood is harvested at birth. Beyond core stem cell banking, the company offers supporting pregnancy-education content and streaming childbirth preparation courses led by midwives.
Product overview
Sevibe Cells operates as a family stem cell banking service within the FamiCord Group, offering umbilical cord blood and tissue stem cell collection, processing, and long-term cryopreservation. The core service is the conservation of stem cells for autologous (family) use. Additional services include online childbirth preparation courses and pregnancy education content through their blog. The company maintains two processing laboratories in Spain (Madrid and Girona) and is accredited by the AABB.
Differentiator
Problem solved
Functional benefit
Products and services
- Umbilical Cord Blood Stem Cell Preservation End-to-end service for expectant families in Spain covering collection kit delivery, harvest of umbilical cord blood at partner hospitals, laboratory processing and testing, and long-term cryopreservation of hematopoietic stem cells for autologous (family) future medical use. Service includes ongoing annual storage.
- Umbilical Cord Tissue Stem Cell Preservation
Quantifiable outcome
- More than 1,000,000 stem cell samples stored globally through FamiCord Group
- +1 more outcomes
Companies that use Sevibe Cells
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Sevibe Cells technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Sevibe Cells partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- FamiCord GroupflagshipSevibe Cells is a subsidiary of FamiCord Group, the largest cord blood banking group in Europe and #3 worldwide. The partnership provides Sevibe with access to FamiCord's network of 14 laboratories worldwide, 1,500+ hospital partnerships, 20+ years of experience, and over 1,000,000 stored samples. FamiCord operates as the parent company providing shared infrastructure, expertise, and brand credibility across European markets including Albania, Germany, Bosnia, Bulgaria, Croatia, Cyprus, Denmark, Slovakia, Slovenia, Spain, Estonia, UK, Hungary, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Macedonia, Montenegro, Poland, Portugal, Czech Republic, Romania, Serbia, Sweden, Switzerland, Turkey, Hong Kong, Kuwait, Lebanon, UAE, and South Africa.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Sevibe Cells competitors and assessment
Company assessmentDirect peers
- Smart Cells: UK-based cord blood bank part of FamiCord Group. Provides autologous cord blood and tissue storage to expectant parents; same business model and parent infrastructure as Sevibe but serving a different geography.
- Crioestaminal: Portuguese cord blood bank also under FamiCord Group. Operates the same autologous cord blood storage model with hospital collection network, AABB-aligned processing, and direct-to-consumer marketing — most directly comparable sibling to Sevibe in Iberia.
- Sorgente Vita: Italian FamiCord subsidiary operating autologous cord blood banking with similar hospital collection, processing and DTC marketing; another in-group direct comparable to Sevibe.
- PBKM (Polski Bank Komórek Macierzystych): Poland's leading cord blood bank and another FamiCord Group subsidiary. Same autologous preservation service, hospital collection footprint, and multi-channel DTC acquisition; comparable scale and business model.
- Cellaviva: Swedish/Danish cord blood bank under FamiCord Group. Offers the same autologous stem cell storage service and hospital collection model in the Nordic market; closest direct sister to Sevibe in Northern Europe.
- Eticur: German autologous cord blood bank under FamiCord Group. Directly comparable service offering and operating model, focused on the DACH market; another sister entity to Sevibe.
Broad incumbents
- ViaCord (Revvity): US private cord blood bank owned by Revvity (formerly PerkinElmer). Comparable autologous cord blood banking service and recurring storage model; larger, broader-portfolio incumbent operating in the US market.
- Cryo-Cell International: US-listed pioneer of private cord blood banking with a global installed base and multi-decade storage revenue stream. Serves a similar autologous-use value proposition but at much greater scale and as an established public incumbent.
Regional players
- Cells4Life: UK-based private cord blood and tissue bank with European operations. Offers autologous and family banking comparable to Sevibe's core service, but with primary geographic focus on the UK rather than Iberia.
- Future Health Biobank: UK-headquartered private stem cell and cord blood bank with multi-country presence in Europe. Comparable autologous and family-banking service offering; serves overlapping European customers but is headquartered in the UK rather than Spain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sevibe Cells social profiles
Digital presenceSevibe Cells compliance and trust
Trust signalCompliance2 records
Sevibe Cells financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sevibe Cells leadership team
Management profileNumber of profiles
Profiles1 record
Sevibe Cells funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sevibe Cells M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sevibe Cells
What does Sevibe Cells do?
Sevibe Cells is an autologous umbilical cord blood and tissue stem cell bank that collects, processes, tests, and cryopreserves hematopoietic and mesenchymal stem cells at childbirth for potential future family medical use. The company operates two proprietary AABB-accredited processing laboratories in Spain (Madrid and Girona) and delivers the sample collection kits to partner hospitals where cord blood is harvested at birth. Beyond core stem cell banking, the company offers supporting pregnancy-education content and streaming childbirth preparation courses led by midwives.
Is Sevibe Cells a public or private company?
Sevibe Cells is a private company. It is classified as corporate owned and is currently operating.
When was Sevibe Cells founded?
Sevibe Cells was founded in 2004.
Where is Sevibe Cells based?
Sevibe Cells is headquartered in Barcelona, Spain, in the Europe region.
How does Sevibe Cells make money?
One revenue line is on record: umbilical Cord Blood Stem Cell Preservation.
Who are Sevibe Cells's main competitors?
Direct peers on record are Smart Cells, Crioestaminal, Sorgente Vita, PBKM (Polski Bank Komórek Macierzystych), Cellaviva and Eticur. Broad incumbents are ViaCord (Revvity) and Cryo-Cell International. Regional players are Cells4Life and Future Health Biobank.
Does Sevibe Cells have an API?
No public API is recorded for Sevibe Cells.
What industry is Sevibe Cells in?
Sevibe Cells's product category is Cord Blood Banking / Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its SIC code is 2835.